Viva Biotech Honored for AI-Driven Drug Discovery Innovations

September 29, 2025
Viva Biotech has been recognized with Frost & Sullivan's 2025 APAC Technology Innovation Leadership award for its AI-driven drug discovery platforms, which enhance efficiency and reduce costs in pharmaceutical R&D.

Viva Biotech has been awarded the 2025 APAC Technology Innovation Leadership recognition by Frost & Sullivan for its pioneering AI-driven drug discovery platforms. Announced in a press release, the award acknowledges Viva Biotech's efforts in accelerating drug discovery timelines, reducing costs, and expanding therapeutic innovation within the global pharmaceutical R&D ecosystem.

Viva Biotech's AI-Driven Drug Discovery (AIDD) platform, which includes the V-Scepter, V-Orb, and V-Mantle modules, integrates predictive modeling, physics-based simulations, and generative AI with laboratory validation. This approach has enabled the company to support over 150 projects for more than 50 global clients, achieving 30-50% faster discovery and up to 70% cost savings.

The recognition highlights Viva Biotech's leadership in combining AI with laboratory-driven validation to reshape drug discovery, strengthen client partnerships, and deliver scalable innovation. The company's platform supports diverse modalities, including small molecules, antibodies, and emerging therapies, significantly reducing development timelines and costs for global clients.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

09/27
Fuse Oncology Showcases AI Solutions at ASTRO 2025
09/26
Elsevier Appoints Brent Gordon as President of Healthcare Education
09/26
Deep EigenMatics Secures US Patent for AI-Driven Protein Design
09/26
Eli Lilly Opens New Gateway Labs in San Diego
09/26
BetterAge Secures $5.5M in NIH Grants for Aging Platform

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like